H. J. M. van Kan
Necmettin Erbakan University(TR)
Publications by Year
Research Areas
Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Pharmaceutical Practices and Patient Outcomes, Synthetic Organic Chemistry Methods, Antifungal resistance and susceptibility
Most-Cited Works
- → Riluzole serum concentrations in patients with ALS(2003)45 cited
- → Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis(2005)41 cited
- → Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS(2001)38 cited
- → Clinically relevant potential drug-drug interactions in intensive care patients: A large retrospective observational multicenter study(2020)36 cited
- → Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study(2020)27 cited
- → A validated HPLC assay to monitor riluzole plasma or serum concentrations in patients with amyotrophic lateral sclerosis(2004)25 cited
- → Acute kidney injury associated with nephrotoxic drugs in critically ill patients: a multicenter cohort study using electronic health record data(2023)19 cited
- → Plasma concentrations of meperidine and normeperidine following continuous intrathecal meperidine in patients with neuropathic cancer pain(2005)16 cited
- → High mortality among patients with bacterial meningitis in a rural hospital in Tanzania(2004)13 cited
- → Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype(2007)12 cited